Hui Chai
Lanzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Nerandomilast alleviates myositis-associated interstitial lung disease by modulating the non-Smad signalling pathway and activating the cAMP-PKA-RhoA pathway.
Journal: RMD open
Published: January 04, 2026
Targeting ERK1/2 attenuates neutrophil extracellular traps-mediated pro-inflammatory and pro-fibrotic effects in myositis-associated interstitial lung disease.
Journal: Rheumatology (Oxford, England)
Published: October 26, 2025
Anlotinib ameliorates myositis-associated interstitial lung disease (MAILD) via suppression of the NETs-PI3K/Akt-driven epithelial-mesenchymal transition.
Journal: RMD open
Published: October 14, 2025
Baricitinib alleviates myositis-associated interstitial lung disease in mice by inhibiting the NETs-cGAS-STING-EMT axis.
Journal: International immunopharmacology
Published: May 01, 2025
Interleukin-33 Promotes Interstitial Lung Disease in Idiopathic Inflammatory Myopathy Via ERK-Mediated Epithelial-Mesenchymal Transition: ERK as a Potential Therapeutic Target.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: April 16, 2025
Review of stimulation parameters of scalp-electroacupuncture for ischemic stroke
Journal: Zhen ci yan jiu = Acupuncture research
Published: October 14, 2024
cPKCγ Inhibits Caspase-9-Initiated Neuronal Apoptosis in an Ischemia Reperfusion Model In Vitro Through p38 MAPK-p90RSK-Bad Pathway.
Journal: Neurochemical research
Published: August 15, 2021
Dysregulation of the miR-1275/HK2 Axis Contributes to the Progression of Hypoxia/Reoxygenation-Induced Myocardial Injury.
Journal: Archives of medical research
Published: January 17, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026